Stable Isotope Labeled Compounds Market by Type (C13, D, 018, N15 label), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital) - Global Forecast to 2022

 Published On: Jul, 2017 |    No of Pages: 136 |  Published By: MarketsandMarkets | Format: PDF
Request Free Sample
The stable isotope-labeled compounds market is projected to grow at a CAGR of 2.94%.
The global stable isotope-labeled compounds market is estimated to grow at a CAGR of 2.94% from 2017 to 2022, to reach USD 294.2 million by 2022. Increase in research activities in the pharmaceutical and biotechnology sector, growing proteomics research, and rising prevalence of cancer are the major factors driving the growth of this market. However, the high cost of stable isotope-labeled compounds is expected to hinder the growth of the market to a certain extent during the forecast period.

The Deuterium (H-2) segment is expected to grow at the highest CAGR during the forecast period.
On the basis of type, the stable isotope-labeled compounds market is segmented into Carbon-13, Deuterium (H-2), Oxygen-18, Nitrogen-15, and others (noble gases and metals). In 2017, the H-2 segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR during the forecast period. Increasing use of H-2 in several research and industrial applications is expected to drive the growth of this market segment.

The pharmaceutical & biotechnology companies segment is projected to grow at the highest CAGR during the forecast period.
Based on end user, the stable isotope-labeled compounds market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic centers, academic & research institutes, and other end users (contract research organizations, food & beverage companies, and forensic laboratories). During the forecast period, the pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR. This growth is mainly due to the increased use of stable isotope-labeled compounds in R&D in the pharmaceutical and biotechnology sector.

North America to witness the highest growth during the forecast period.
In 2017, North America is projected to account for the largest share of the global stable isotope-labeled compounds market. Growth of the pharmaceutical and biopharmaceutical industry, support for this sector from the Isotope Production and Distribution Program Fund, the presence of a large nuclear industry in the U.S, growth of the Canadian pharmaceutical industry, and the rising adoption of PET imaging in Canada are the key factors responsible for the growth of this market in the North America region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–85%, Tier 2–9% and Tier 3–6%
• By Designation – C-level–81%, Director Level–10%, Others–9%
• By Region – North America–40%, Europe–20%, Asia-Pacific–29%, RoW–11%

Some of the major players in the stable isotope-labeled compounds market include Cambridge Isotopes Laboratories, Inc. (U.S.), Merck KGaA (Germany), URENCO (U.K.), Omicron Biochemicals, Inc. (U.S.), JSC Isotope (Russia), Trace Science International (U.S.), IsoSciences (U.S.), Taiyo Nippon Sanso Corporation (Japan), Nordion Inc. (Canada), and Medical Isotopes, Inc. (U.S.).

Research Coverage:
The report analyzes the stable isotope-labeled compounds market and aims at estimating the market size and future growth potential based on various segments such as type, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global stable isotope-labeled compounds market. The report analyzes the global market by type, application, end user, and region
• Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global stable isotope-labeled compounds market
• Market Development: Comprehensive information on the lucrative emerging markets by type of stable isotope-labeled compounds, application, end user, and region
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global stable isotope-labeled compounds market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, services, and capabilities of reprocessing of stable isotope-labeled compounds of leading players in the global market
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 14
1.2.2 YEARS CONSIDERED FOR THE STUDY 14
1.3 CURRENCY 15
1.4 LIMITATIONS 15
1.5 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH METHODOLOGY STEPS 16
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 17
2.1.1.1 Key data from secondary sources 17
2.2 MARKET SIZE ESTIMATION METHODOLOGY 21
2.3 MARKET FORECAST METHODOLOGY 23
2.4 MARKET DATA VALIDATION AND TRIANGULATION 24
3 EXECUTIVE SUMMARY 25
3.1 INTRODUCTION 25
4 PREMIUM INSIGHTS 28
4.1 STABLE ISOTOPE-LABELED COMPOUNDS: MARKET OVERVIEW 28
4.2 GEOGRAPHIC ANALYSIS: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER (2017) 29
4.3 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017 VS. 2022 30
4.4 GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Increase in research activities in the pharmaceutical and biotechnology sector 33
5.2.1.2 Growing proteomics research 33
5.2.1.3 Rising prevalence of cancer 33
5.2.2 RESTRAINT 34
5.2.2.1 High cost of stable isotope-labeled compounds 34
5.2.3 OPPORTUNITY 34
5.2.3.1 Rising investments in pharmaceutical R&D in emerging markets 34
5.2.4 CHALLENGE 35
5.2.4.1 Dearth of skilled professionals 35
6 GLOBAL STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE 36
6.1 INTRODUCTION 37
6.2 DEUTERIUM 37
6.3 CARBON-13 38
6.4 OXYGEN-18 39
6.5 NITROGEN-15 40
6.6 OTHER STABLE ISOTOPES 40
7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION 42
7.1 INTRODUCTION 43
7.2 RESEARCH 43
7.2.1 BIOMEDICAL RESEARCH 43
7.2.2 PHARMACEUTICAL RESEARCH 44
7.2.3 ENVIRONMENTAL & ECOLOGICAL RESEARCH 44
7.2.4 AGRICULTURAL RESEARCH 44
7.3 CLINICAL DIAGNOSTICS 45
7.4 INDUSTRIAL 46
7.5 OTHER APPLICATIONS 46
8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER 48
8.1 INTRODUCTION 49
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 49
8.3 ACADEMIC & RESEARCH INSTITUTES 50
8.4 HOSPITALS AND DIAGNOSTIC CENTERS 51
8.4.1 OTHER END USERS 51
9 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION 53
9.1 INTRODUCTION 54
9.2 NORTH AMERICA 55
9.2.1 U.S. 57
9.2.1.1 Growth of the U.S. Pharmaceutical and Biopharmaceutical Industries 57
9.2.1.2 Support from the Isotope Production and Distribution Program Fund 57
9.2.1.3 Strong Nuclear Industry in the U.S. 58
9.2.2 CANADA 59
9.2.2.1 Growth of the Pharmaceutical Industry 59
9.2.2.2 Rising Adoption of PET Imaging 60
9.3 EUROPE 62
9.3.1 GERMANY 64
9.3.1.1 Increasing pharmaceutical R&D 64
9.3.1.2 Presence of large number of research institutes and CROs 65
9.3.2 U.K. 66
9.3.2.1 Increasing Number of PET-CT Procedures 66
9.3.2.2 Favorable Scenario for Environmental Research 67
9.3.3 FRANCE 69
9.3.3.1 Rising metabolomics research 69
9.3.4 REST OF EUROPE (ROE) 71
9.3.4.1 Rising pharmaceutical R&D expenditure 71
9.4 ASIA-PACIFIC 73
9.4.1.1 Rising nuclear energy generation 76
9.4.2 CHINA 76
9.4.2.1 Favorable scenario for clinical research 76
9.4.3 JAPAN 78
9.4.3.1 Growth in biomedical and medical research 78
9.4.4 INDIA 80
9.4.4.1 Strong heavy water production capabilities 80
9.4.4.2 Increasing pharmaceutical R&D 80
9.4.5 REST OF ASIA-PACIFIC (ROAPAC) 82
9.4.5.1 Rising Pharmaceutical Research in South Korea 82
9.4.5.2 Establishment of R&D centers in singapore 83
9.5 REST OF THE WORLD 85
9.5.1 INCREASING PHARMACEUTICAL RESEARCH 86
10 COMPETITIVE LANDSCAPE 88
10.1 INTRODUCTION 88
10.2 MARKET SHARE ANALYSIS 88
10.3 COMPETITIVE LEADERSHIP MAPPING 89
10.3.1 VISIONARY LEADERS 89
10.3.2 INNOVATORS 89
10.3.3 DYNAMIC DIFFERENTIATORS 90
10.3.4 EMERGING COMPANIES 90
10.4 BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS) 91
10.5 STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS) 92
*Top 25 companies analyzed for this studies are - Cambridge Isotopes Laboratories, Inc., Merck KGaA, URENCO Limited, IsoSciences, LLC., Medical Isotopes, Inc., Omicron, Biochemicals, Inc., Nordion (Canada) Inc., Trace Sciences International, ALSACHIM, Taiyo Nippon Sanso Corporation, Rotem Industries Israel Ltd., Marshall Isotopes Ltd., Centre of Molecular Research, JSC Isotope, SI Science Co. Ltd., Shanghai Research Institute of Chemical Industry, Los Alamos National Laboratory, Oak Ridge National Laboratory,  3M, JSC Atomenergoprom, The Linde Group, PerkinElmer, Inc., C D N Isotopes Inc., 13 C molecular, Isoflex

11 COMPANY PROFILES 93
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 CAMBRIDGE ISOTOPE LABORATORIES, INC. 93
11.2 MERCK KGAA 97
11.3 URENCO LIMITED 101
11.4 ISOSCIENCES, LLC (AN MDP CHEMICALS COMPANY) 104
11.5 MEDICAL ISOTOPES, INC. 106
11.6 OMICRON BIOCHEMICALS, INC. 108
11.7 NORDION (CANADA) INC. (A STERIGENICS INTERNATIONAL LLC COMPANY) 110
11.8 TRACE SCIENCES INTERNATIONAL 113
11.9 ALSACHIM 115
11.10 TAIYO NIPPON SANSO CORPORATION 117
11.11 PERKINELMER INC. 120
11.12 ROTEM INDUSTRIES ISRAEL LTD 123

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 125
12.1 DISCUSSION GUIDE 125
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 128
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 130
12.3.1 FEATURES AND BENEFITS OF RT: 130
12.4 AVAILABLE CUSTOMIZATIONS 131
12.5 RELATED REPORTS 132
12.6 AUTHOR DETAILS 133   

LIST OF TABLES

TABLE 1 GOVERNMENT FUNDING PROGRAMS FOR PHARMACEUTICAL R&D IN EMERGING NATIONS 34
TABLE 2 STABLE ISOTOPE-LABELED COMPOUNDS MARKET SIZE, BY TYPE, 2017–2022 (USD MILLION) 37
TABLE 3 H-2-LABELED COMPOUNDS MARKET SIZE, BY REGION, 2017–2022 (USD MILLION) 38
TABLE 4 C-13-LABELED COMPOUNDS MARKET SIZE, BY REGION, 2017–2022 (USD MILLION) 38
TABLE 5 O-18-LABELED COMPOUNDS MARKET SIZE, BY REGION, 2017–2022 (USD MILLION) 39
TABLE 6 N-15-LABELED COMPOUNDS MARKET SIZE, BY REGION, 2017–2022 (USD MILLION) 40
TABLE 7 OTHER STABLE ISOTOPE-LABELED COMPOUNDS MARKET SIZE, BY REGION, 2017–2022 (USD MILLION) 41
TABLE 8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 43
TABLE 9 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 10 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 11 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 46
TABLE 12 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 13 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 49
TABLE 14 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 15 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 16 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 17 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 18 GLOBAL STABLE ISOTOPE-LABELED COMPOUNDS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 54
TABLE 19 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 20 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 56
TABLE 21 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 56
TABLE 22 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 57
TABLE 23 U.S.: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 58
TABLE 24 U.S.: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 59
TABLE 25 U.S.: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 59
TABLE 26 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 60
TABLE 27 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 61
TABLE 28 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 61
TABLE 29 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 63
TABLE 30 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 63
TABLE 31 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 64
TABLE 32 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 64
TABLE 33 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 65
TABLE 34 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 65
TABLE 35 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 66
TABLE 36 U.K.: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 67
TABLE 37 U.K.: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 68
TABLE 38 U.K.: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 68
TABLE 39 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 69
TABLE 40 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 70
TABLE 41 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 70
TABLE 42 PHARMACEUTICAL R&D EXPENDITURE IN ROE COUNTRIES 71
TABLE 43 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 71
TABLE 44 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 72
TABLE 45 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 72
TABLE 46 ASIA-PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 74
TABLE 47 ASIA-PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 74
TABLE 48 ASIA-PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 75
TABLE 49 ASIA-PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 75
TABLE 50 NUMBER OF NUCLEAR REACTORS IN ASIA-PACIFIC REGION (JANUARY 2016) 76
TABLE 51 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 77
TABLE 52 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 77
TABLE 53 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 78
TABLE 54 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 79
TABLE 55 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 79
TABLE 56 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 80
TABLE 57 INDIA: HEAVY WATER EXPORTS, 2016 80
TABLE 58 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 59 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 81
TABLE 60 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 82
TABLE 61 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 83
TABLE 62 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 84
TABLE 63 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 84
TABLE 64 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2015–2022 (USD MILLION) 86
TABLE 65 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 86
TABLE 66 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 87

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET 16
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 19
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 20
FIGURE 5 KEY INDUSTRY INSIGHTS 21
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22
FIGURE 8 RESEARCH DESIGN: GLOBAL STABLE ISOTOPE-LABELED COMPOUNDS MARKET 23
FIGURE 9 DATA TRIANGULATION METHODOLOGY 24
FIGURE 10 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017 25
FIGURE 11 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017 VS. 2022 26
FIGURE 12 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017 VS. 2022 26
FIGURE 13 GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET 27
FIGURE 14 INCREASE IN RESEARCH ACTIVITIES IN THE PHARMACEUTICAL AND BIOTECHNOLOGY SECTOR—KEY GROWTH DRIVER OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET IN THE FORECAST PERIOD 28
FIGURE 15 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET IN 2017 29
FIGURE 16 RESEARCH APPLICATION SUB-SEGMENT WILL CONTINUE TO DOMINATE THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET IN 2022 30
FIGURE 17 NORTH AMERICA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2017–2022) 30
FIGURE 18 STABLE ISOTOPE-LABELED COMPOUNDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 32
FIGURE 19 NORTH AMERICA TO DOMINATE THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET IN 2017 54
FIGURE 20 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT 55
FIGURE 21 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT 62
FIGURE 22 ASIA-PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT 73
FIGURE 23 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT 85
FIGURE 24 GLOBAL STABLE ISOTOPE-LABELED COMPOUNDS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 88
FIGURE 25 STABLE ISOTOPE-LABELED COMPOUNDS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017 90
FIGURE 26 MERCK KGAA: COMPANY SNAPSHOT (2016) 97
FIGURE 27 URENCO LIMITED: COMPANY SNAPSHOT (2016) 101
FIGURE 28 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2016) 117
FIGURE 29 PERKINELMER INC.: COMPANY SNAPSHOT (2016) 120

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.